Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The crystal structures of the human androgen receptor (hAR) and human progesterone receptor ligand-binding domains in complex with the same ligand metribolone (R1881) have been determined. Both three-dimensional structures show the typical nuclear receptor fold. The change of two residues in the ligand-binding pocket between the human progesterone receptor and hAR is most likely the source for the specificity of R1881 to the hAR. The structural implications of the 14 known mutations in the ligand-binding pocket of the hAR ligand-binding domains associated with either prostate cancer or the partial or complete androgen receptor insensitivity syndrome were analyzed. The effects of most of these mutants could be explained on the basis of the crystal structure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LBD and DBD X-ray crystal structures of AR have been solved separately (Matias et al., 2000; Sack et al., 2001; Shaffer et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Matias et al., 2000
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953
Research works printed but not linked: 8
- Otwinowski, 1997, 276, 307
- Lamzin, 1997, 277, 269
- Kleywegt, 1995, Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, 31, 45
- Bellis, 1992, Mol. Endocrinol., 6, 1909
- Pinsky, 1992, Clin. Invest. Med., 15, 456
- Lumbroso, 1996, J. Clin. Endocrinol. & Metab., 81, 1984
- Jakubicza, 1992, Hum. Genet., 90, 311
- Nakao, 1992, J. Clin. Endocrinol. & Metab., 74, 1152
Cited by
Items 301–400 of 696
Advances in the computational development of androgen receptor antagonists
Hu, X., Chai, X., Wang, X., Duan, M., Pang, J., Fu, W., Li, D., & Hou, T. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.004 · Cited by 25
Fagart, J., Seguin, C., Pinon, G. M., & Rafestin-Oblin, M. E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010710 · Cited by 25
Elhaji, Y. A., Wu, J. H., Gottlieb, B., Beitel, L. K., Alvarado, C., Batist, G., & Trifiro, M. A. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0023 · Cited by 24
Narayanan, R., Yepuru, M., Szafran, A. T., Szwarc, M. M., Bohl, C. E., Young, N. L., Miller, D. D., Mancini, M. A., & Dalton, J. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3206 · Cited by 24
Shi, Y., & Koh, J. T. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00028-x · Cited by 24
Elhaji, Y. A., Stoica, I., Dennis, S., Purisima, E. O., & Trifiro, M. A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl009 · Cited by 24
Xu, X. J., Yang, W., Wang, X., Li, Y., Wang, Y., & Ai, C. (2011) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22951 · Cited by 24
Baker, M. E., & Chandsawangbhuwana, C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.110 · Cited by 24
Ivachtchenko, A. V., Ivanenkov, Y. A., Mitkin, O. D., Vorobiev, A. A., Kuznetsova, I. V., Shevkun, N. A., Koryakova, A. G., Karapetian, R. N., Trifelenkov, A. S., Kravchenko, D. V., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.039 · Cited by 24
Tadokoro‐Cuccaro, R., Bunch, T., Schwabe, J. W. R., Hughes, I. A., & Murphy, J. C. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03462.x · Cited by 24
Singh, A. S., Chau, C. H., Price, D. K., & Figg, W. D. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0091 · Cited by 24
Gilli, P., Gilli, G., Borea, P. A., Varani, K., Scatturin, A., & Dalpiaz, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040842z · Cited by 24
Erzurumlu, Y., & Muhammed, M. T. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110745 · Cited by 23
MacLean, H. E., Ball, E. M. A., Rekaris, G., Warne, G. L., & Zajac, J. D. (2004) · Human Mutation · doi:10.1002/humu.9221 · Cited by 23
Huang, H., Si, P., Wang, L., Xu, Y., Xu, X., Zhu, J., Jiang, H., Li, W., Chen, L., & Li, J. (2015) · ChemMedChem · doi:10.1002/cmdc.201500136 · Cited by 23
Sobhani, N., Generali, D., D’Angelo, A., Aieta, M., & Roviello, G. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0653-2 · Cited by 23
Szafran, A. T., Hartig, S. M., Sun, H., Uray, I. P., Szwarc, M. M., Shen, Y., Mediwala, S. N., BELL, J. J., McPhaul, M. J., Mancini, M. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008179 · Cited by 23
Development of p-carborane-based nonsteroidal progesterone receptor antagonists
Fujii, S., Nakano, E., Yanagida, N., Mori, S., Masuno, H., & Kagechika, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.049 · Cited by 23
Hillisch, A., von Langen, J., Menzenbach, B., Droescher, P., Kaufmann, G., Schneider, B., & Elger, W. A. G. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.009 · Cited by 23
Peng, S., Wang, J., Chen, H., Hu, P., He, X., He, Y., Wang, M., Tang, W., He, Q.-R., Wang, Y., et al. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09511-x · Cited by 22
QSAR of Progestogens: Use of a Priori and Computed Molecular Descriptors and Molecular Graphics
Kiralj, R., Takahata, Y., & Ferreira, M. M. C. (2003) · QSAR & Combinatorial Science · doi:10.1002/qsar.200390033 · Cited by 22
R726L androgen receptor mutation is uncommon in prostate cancer families in the united states
Gruber, S. B., Chen, H., Tomsho, L. P., Lee, N., Perrone, E. E., & Cooney, K. A. (2003) · The Prostate · doi:10.1002/pros.10195 · Cited by 22
Erzurumlu, Y., Aydoğdu, E., Doğan, H. K., Çataklı, D., Muhammed, M. T., & Buyuksandic, B. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110577 · Cited by 21
Liu, Q., Yin, X., & Li, P. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01894-4 · Cited by 21
Correlated Evolution of Androgen Receptor and Aromatase Revisited
Reitzel, A. M., & Tarrant, A. M. (2010) · Molecular Biology and Evolution · doi:10.1093/molbev/msq129 · Cited by 21
Allen, T. E. H., Liggi, S., Goodman, J. M., Gutsell, S., & Russell, P. J. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00101 · Cited by 21
Computational investigation of four isoquinoline alkaloids against polycystic ovarian syndrome
Moka, M. K., Ankul Singh, S., & Mohan, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2222828 · Cited by 21
Five novel androgen receptor gene mutations associated with complete androgen insensitivity syndrome
Jääskeläinen, J., Mongan, N. P., Harland, S., & Hughes, I. A. (2006) · Human Mutation · doi:10.1002/humu.9405 · Cited by 21
Androgen-selective gene regulation in the prostate
Haendler, B. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00159-7 · Cited by 20
Wang, S., Lin, T., Peng, T., Xing, E., Chen, S., Kara, L. B., & Cheng, X. (2025) · Chemical Science · doi:10.1039/d4sc05211k · Cited by 20
Colleta, S. J., Antoniassi, J. Q., Zanatelli, M., dos Santos, F. C. A., Góes, R. M., Vilamaior, P. S. L., & Taboga, S. R. (2015) · Environmental Toxicology · doi:10.1002/tox.22211 · Cited by 20
Treatments Targeting the Androgen Receptor and Its Splice Variants in Breast Cancer
Tien, A. H., & Sadar, M. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031817 · Cited by 20
de Albuquerque, A. C. C., Bezerra, K. S., Vianna, J. F., Batista, S. D. O., Neto, J. X., Campos, D. M. D. O., Oliveira, J. I. N., Galvao, D. S., & Fulco, U. L. (2023) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.3c01103 · Cited by 20
Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development
Ittiwut, C., Pratuangdejkul, J., Supornsilchai, V., Muensri, S., Hiranras, Y., Sahakitrungruang, T., Watcharasindhu, S., Suphapeetiporn, K., & Shotelersuk, V. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0048 · Cited by 20
Korlyukov, A. A., Malińska, M., Vologzhanina, A. V., Гойзман, М. С., Trzybiński, D., & Woźniak, K. (2020) · IUCrJ · doi:10.1107/s2052252519014416 · Cited by 20
Tian, H., Yuan, X., Lu, J., Li, J., Luo, C., Ye, W., & Jiang, R. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.10.020 · Cited by 20
Thin, T. H., Wang, L., Kim, E., Collins, L. L., Basavappa, R., & Chang, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206172200 · Cited by 20
James, J. P., Kumar, P., Kumar, A., Bhat, K. I., & Shastry, C. S. (2020) · Letters in Drug Design & Discovery · doi:10.2174/1570180817999200730164222 · Cited by 20
Chinta, G., Mariasoosai, C., Klopčič, I., Dolenc, M. S., Periyasamy, L., & Coumar, M. S. (2015) · Planta Medica · doi:10.1055/s-0035-1546082 · Cited by 19
Erzurumlu, Y., Doğan, H. K., Çataklı, D., Aydoğdu, E., & Muhammed, M. T. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-022-00720-z · Cited by 19
Bobach, C., Tennstedt, S., Palberg, K., Denkert, A., Brandt, W., de Meijere, A., Seliger, B., & Wessjohann, L. A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.11.026 · Cited by 19
Umar, A., Berrevoets, C., Van, N. M., van Leeuwen, M., Verbiest, M. M. P. J., Kleijer, W. J., Dooijes, D., Grootegoed, J. A., Drop, S. L. S., & Brinkmann, A. O. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0057 · Cited by 19
Parasites of South African wildlife. III. Helminths of common reedbuck, Redunca arundinum, in Natal.
Boomker, J., Horak, I. G., Flamand, J. R., & Keep, M. E. (1989) · PubMed · Cited by 19
James, A. J., Agoulnik, I. U., Harris, J. M., Buchanan, G., Tilley, W. D., Marcelli, M., Lamb, D. J., & Weigel, N. L. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0281 · Cited by 21
Söderholm, A. A., Lehtovuori, P. T., & Nyrönen, T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060234e · Cited by 19
Infante, J. B., Alvelos, M. I., Bastos, M., Carrilho, F., & Lemos, M. C. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.042 · Cited by 19
Ramana, P. V., Krishna, Y. R., & Mouli, K. C. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133984 · Cited by 19
Burley, S. K., Wu-Wu, A., Dutta, S., Ganesan, S., & Zheng, X. F. S. (2024) · Oncogene · doi:10.1038/s41388-024-03077-2 · Cited by 18
Preković, S., den Broeck, T. V., Moris, L., Smeets, E., Claessens, F., Joniau, S., Helsen, C., & Attard, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.020 · Cited by 18
Dey, R., Roychowdhury, P., & Mukherjee, C. (2001) · Protein Engineering Design and Selection · doi:10.1093/protein/14.8.565 · Cited by 18
Fujii, S., Ohta, K., Goto, T., Oda, A., Masuno, H., Endo, Y., & Kagechika, H. (2012) · MedChemComm · doi:10.1039/c2md00294a · Cited by 18
Thomas, E. B., Thankan, R. S., Purushottamachar, P., Huang, W., Kane, M. A., Zhang, Y., Ambulos, N. P., Weber, D. J., & Njar, V. C. O. (2022) · Cells · doi:10.3390/cells11172699 · Cited by 18
Molecular pathogenesis of spinal and bulbar muscular atrophy
Merry, D. E. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00594-9 · Cited by 18
Differential interaction of RU486 with the progesterone and glucocorticoid receptors
Zhang, J., Tsai, F. T. F., & Geller, D. S. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02089 · Cited by 18
Ai, N., DeLisle, R. K., Yu, S. J., & Welsh, W. J. (2003) · Chemical Research in Toxicology · doi:10.1021/tx034168k · Cited by 18
Nagy, A. M., Abdelhameed, M. F., Elkarim, A. S. A., Sarker, T. C., Abd‐ElGawad, A. M., Elshamy, A. I., & Hammam, A. M. (2024) · Molecules · doi:10.3390/molecules29030735 · Cited by 18
Térouanne, B., Nirdé, P., Rabenoelina, F., Bourguet, W., Sultan, C., & Auzou, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.791 · Cited by 17
Li, F., Song, C. M., Zhang, Y., & Wu, D. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2021001 · Cited by 17
Christiaens, V., Berckmans, P., Haelens, A., Witters, H. E., & Claessens, F. (2005) · Environmental Toxicology and Chemistry · doi:10.1897/05-126r.1 · Cited by 17
Zhou, F., Zhao, W., Zuo, Z., Sheng, Y., Zhou, X. Y., Hou, Y., Cheng, H., & Zhou, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.161968 · Cited by 17
Androgen insensitivity syndrome ten years of our experience
Subramaniam, A., Singh, R., Tilak, P., Devi, R., Kulandaivelu, M., & Kumarasamy, T. (2013) · Frontiers in Bioscience-Elite · doi:10.2741/e658 · Cited by 17
Wu, J. H., Gottlieb, B., Batist, G., Sulea, T. I., Purisima, E. O., Beitel, L. K., & Trifiro, M. A. (2003) · Human Mutation · doi:10.1002/humu.10279 · Cited by 17
Harada, T., Yamagishi, K., Nakano, T., Kitaura, K., & Tokiwa, H. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0268-9 · Cited by 17
Rosa, S., Biason‐Lauber, A., Mongan, N. P., Navratil, F., & Schoenle, E. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020139 · Cited by 16
Gad, Y. Z., Mazen, I., Lumbroso, S., Temtamy, S. A., & Sultan, C. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.630109.x · Cited by 16
Androgen Receptor in Hormone Receptor-Positive Breast Cancer
Khan, A. F., Karami, S., Peidl, A. S., Waiters, K. D., Babajide, M. F., & Bawa‐Khalfe, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010476 · Cited by 16
Therapeutic androgen receptor ligands
Allan, G. F., & Sui, Z. (2003) · Nuclear Receptor Signaling · doi:10.1621/nrs.01009 · Cited by 16
The Binding Mode of Progesterone to Its Receptor Deduced from Molecular Dynamics Simulations
Mordasini, T. Z., Curioni, A., Bursi, R., & Andreoni, W. (2003) · ChemBioChem · doi:10.1002/cbic.200390026 · Cited by 16
Structural basis of ICF-causing mutations in the methyltransferase domain of DNMT3B
Lappalainen, I., & Vihinen, M. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.12.1005 · Cited by 16
The role of cofactors in sex steroid action
Trapman, J., & Dubbink, H. J. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.002 · Cited by 15
Jeske, Y. W. A., McGown, I. N., Cowley, D. M., Oley, C., Thomsett, M. J., Choong, C. S., & Cotterill, A. M. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.8.893 · Cited by 15
Selective androgen receptor modulators
Chengalvala, M., Oh, T. T., & Roy, A. K. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.1.59 · Cited by 15
New Insights into the Androgen-Targeted Therapies and Epigenetic Therapies in Prostate Cancer
Godbole, A. M., & Njar, V. C. O. (2011) · Prostate Cancer · doi:10.1155/2011/918707 · Cited by 15
Shao, J., Hou, J., Li, B., Li, D., Zhang, N., & Wang, X. (2015) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2014.01035 · Cited by 15
Werner, R., Schütt, J., Hannema, S. E., Röpke, A., Wieacker, P. F., Hiort, O., & Holterhus, P. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.06.016 · Cited by 15
Ben‐Eltriki, M., Deb, S., Hassona, M. M., Meckling, G. R., Fazli, L., Chin, M. Y., Lallous, N., Yamazaki, T., Jia, W. W.-G., Rennie, P. S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24695 · Cited by 15
3D Model of Lamprey Estrogen Receptor with Estradiol and 15α-Hydroxy-Estradiol
Baker, M. E., Chang, D. J., & Chandsawangbhuwana, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006038 · Cited by 15
Nagata, N., Kawai, K., & Nakanishi, I. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300219g · Cited by 15
Wong, H. Y., Hoogerbrugge, J. W., Pang, K. L., van Leeuwen, M., van Royen, M. E., Molier, M., Berrevoets, C., Dooijes, D., Dubbink, H. J., van de Wijngaart, D. J., et al. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.016 · Cited by 14
Concepts and Updates in the Evaluation and Diagnosis of Common Disorders of Sexual Development
Rawal, A., & Austin, P. F. (2015) · Current Urology Reports · doi:10.1007/s11934-015-0556-0 · Cited by 14
Recent advances in dietary androgen receptor inhibitors
Ren, L., Zhang, T., & Zhang, J. (2024) · Medicinal Research Reviews · doi:10.1002/med.22019 · Cited by 14
Petroli, R. J., Maciel‐Guerra, A. T., Soardi, F. C., de Calais, F. L., Guerra‐Júnior, G., & de Mello, M. P. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-173 · Cited by 14
Yoshino, H., Sato, H., Tachibana, K., Shiraishi, T., Nakamura, M., Ohta, M., Ishikura, N., Nagamuta, M., Onuma, E., Nakagawa, T., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.036 · Cited by 14
Tachibana, K., Imaoka, I., Yoshino, H., Emura, T., Kodama, H., Furuta, Y., Kato, N., Nakamura, M., Ohta, M., Taniguchi, K., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.072 · Cited by 14
3D model of amphioxus steroid receptor complexed with estradiolPreprint
Baker, M. E., & Chang, D. J. (2009) · Nature Precedings · doi:10.1038/npre.2009.3316.1 · Cited by 14
Contribution of the androgen receptor to prostate cancer predisposition and progression
Buchanan, G., Irvine, R. A., Coetzee, G. A., & Tilley, W. D. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-48143-x_6 · Cited by 14
Coactivation of an endogenous progesterone receptor by TIF2 in COS-7 cells
Hofman, K., Swinnen, J. V., Verhoeven, G., & Heyns, W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00698-8 · Cited by 14
Tsuji, M. (2013) · Journal of Structural Biology · doi:10.1016/j.jsb.2013.12.007 · Cited by 13
Lumbroso, S., Wagschal, A., Bourguet, W., Georget, V., Mazen, I., Servant, N., Audran, F., Sultan, C., & Auzou, G. (2004) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0320679 · Cited by 13
Das, A., Nandi, A., Kumari, V., & Alvala, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815179934123010008 · Cited by 13
Poujol, N., Lumbroso, S., Térouanne, B., Lobaccaro, J. A., Bourguet, W., & Sultan, C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020491 · Cited by 13
The androgen receptor: molecular biology
Klocker, H., Gromoll, J., & Cato, A. C. B. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545221.003 · Cited by 12
Xie, J., Shen, K., Liang, W., Kuang, Z., Shrestha, R. K., Hanson, A. R., Townley, S. L., He, M., Yu, S., Zhou, P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509222122 · Cited by 12
Perspectives on designs of antiandrogens for prostate cancer
Estébanez‐Perpiñá, E., Jouravel, N., & Fletterick, R. J. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.10.1341 · Cited by 12
Zakharov, M. N., Pillai, B. K., Bhasin, S., Ulloor, J., Istomin, A. Y., Guo, C., Godzik, A., Kumar, P., & Jasuja, R. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.03.003 · Cited by 12
Androgen Insensitivity Syndrome
Sultan, C., Philibert, P., Gaspari, L., Audran, F., Maïmoun, L., Kalfa, N., & Paris, F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00016-8 · Cited by 12
Georget, V., Bourguet, W., Lumbroso, S., Makni, S., Sultan, C., & Nicolas, J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0419 · Cited by 12
Roy, J., Breton, R., Martel, C., Labrie, F., & Poirier, D. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.007 · Cited by 12
Maltais, R., Mercier, C., Labrie, F., & Poirier, D. (2005) · Molecular Diversity · doi:10.1007/s11030-005-1312-z · Cited by 12
Oppong, E. K., Stier, G., Gaal, M., Seeger, R., Stoeck, M., Delsuc, M., Cato, A. C. B., & Kieffer, B. (2017) · Biomolecules · doi:10.3390/biom7020044 · Cited by 11
Metadata
- Authors
- Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., Bäsler, S., Schäfer, M., Egner, U., & Carrondo, M. A.
- Affiliations
- Universidade Nova de Lisboa (PT)
- Instituto de Biologia Experimental e Tecnológica (PT)
- Corresponding author
- Carrondo, Maria Arménia
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26164-26171
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2151922331
- Cited by
- 608
- References
- 53
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 14 · 2023: 20 · 2022: 17 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 23 · 2014: 12 · 2013: 22 · 2012: 17
- FWCI
- 37.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7373 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- androgen receptor, ligand-binding domain, ligand specificity, progesterone receptor, binding pocket, point mutations, prostate cancer, crystal structure
- MeSH terms
- Amino Acid Sequence, Binding Sites, Humans, Ligands, Male, Models, Chemical, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Prostatic Neoplasms, Protein Conformation, Receptors, Androgen, Metribolone, Mutagenesis, Site-Directed, Crystallography, X-Ray, Amino Acid Substitution, Testosterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.